Who makes Wegovy drug?
The medication, Wegovy, is a higher dose of the diabetes drug semaglutide produced by Novo Nordisk. It's the first drug for chronic weight management that has been approved by the FDA since 2014. HealthlineFDA Approves Popular Diabetes Medication for Use as Weight Loss Drug
When can I get Wegovy?
Wegovy is indicated for adults who are obese (body mass index ≥30) or overweight (body mass index ≥27), and who also have certain weight-related medical conditions, such as type 2 diabetes, hypertension, and high cholesterol. ForbesNewly Approved Obesity Drug Wegovy Holds Promise, But Faces Reimbursement Challenges
What is the name of the new weight loss drug approved by the FDA?
June 7, 2021 — The FDA has approved a drug to help in weight loss among overweight or obese adults. The drug, semaglutide, "induces weight loss by reducing hunger, increasing feelings of fullness, and thereby helping people eat less and reduce their calorie intake," according to a company statement. WebMDFDA Approves 'Game Changer' Drug for Weight Loss In clinical trials, participants lost up to 15
How much does Wegovy cost?
Dive Brief: The Food and Drug Administration on Friday approved Novo Nordisk's newest treatment for obesity, a weekly injection called Wegovy. The Danish company followed up Monday with an announcement that it will set the list price at $1,297 a month, equivalent to its daily obesity drug Saxenda. BioPharma DiveNovo keeps price in line with FDA approval of second obesity shot